Previous Close | 65.94 |
Open | 65.62 |
Bid | 61.98 x 100 |
Ask | 65.12 x 200 |
Day's Range | 64.82 - 65.64 |
52 Week Range | 64.63 - 87.87 |
Volume | |
Avg. Volume | 7,429,945 |
Market Cap | 81.128B |
Beta (5Y Monthly) | 0.20 |
PE Ratio (TTM) | 180.72 |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | 3.08 (4.67%) |
Ex-Dividend Date | Jun 14, 2024 |
1y Target Est | N/A |
Gilead Sciences, Inc. (NASDAQ:GILD) Q1 2024 Earnings Call Transcript April 25, 2024 Gilead Sciences, Inc. beats earnings expectations. Reported EPS is $-1.32, expectations were $-1.49. Gilead Sciences, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon, everyone, and […]
Gilead (GILD) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Gilead Sciences ( NASDAQ:GILD ) First Quarter 2024 Results Key Financial Results Revenue: US$6.69b (up 5.3% from 1Q...